Developer docs
API playgroundTry for free, no card

Search company profiles

Sysmex Netherlands & Belgium

Full company profile

uuid005ew7y

Namestring
Sysmex Netherlands & Belgium
Legal namestring
Sysmex Nederland B.V.
Websiteurl
sysmex.nl
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Sysmex Netherlands & Belgium is the Benelux operating arm of Sysmex Corporation, structured as two regional subsidiaries (Sysmex Nederland B.V., headquartered in Etten-Leur, and Sysmex Belgium N.V., in La Hulpe) under Sysmex Europe SE. The business distributes and services a comprehensive in-vitro diagnostics portfolio to clinical laboratories, hospitals, blood banks, oncology centers, and government screening programs in the Netherlands and Belgium, employing approximately 180 staff.

The product platform is anchored by the XN-Series automated hematology analyzers, with proprietary software modules (Blood Bank Mode, Body Fluid Mode, PLT-F fluorescence platelet counting) and an Extended IPU enabling advanced parameters such as ICIS for sepsis screening and MDS-CBC for myelodysplastic syndrome detection. The Life Science portfolio includes the OSNA molecular diagnostic platform for intraoperative sentinel lymph node analysis, OncoBEAM RAS CRC liquid biopsy, SafeSEQ NGS-based ctDNA detection, the XF-1600 10-color flow cytometer, the DI-60 digital imaging system, and the Sentimag magnetic localization system. Adjacent offerings span hemostasis, urinalysis, clinical chemistry, point-of-care testing, veterinary diagnostics, and Industry & Research instrumentation distributed via a partnership with Malvern Panalytical.

Revenue is generated through three streams: capital equipment sales (hematology, flow cytometry, urinalysis analyzers), recurring reagents and consumables tied to the installed base, and multi-year service and maintenance contracts. The go-to-market is direct enterprise field sales combined with in-house technical support, preventive maintenance, and customer training delivered through Caresphere Academy. Customer engagement includes the Dutch National Colorectal Cancer Screening Programme using the SENTiFIT 270 analyzer and FOB Gold reagents, which has scaled to over 1.5 million participants.

Short descriptiontext

Sysmex Netherlands & Belgium is the Benelux sales and service arm of Sysmex Corporation, distributing automated hematology analyzers, flow cytometry, urinalysis, molecular diagnostics, and life science platforms to clinical laboratories, hospitals, blood banks, and government screening programs in the Netherlands and Belgium.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersEtten-Leur, Netherlands
HQ citystring
Etten-Leur
HQ countrystring
Netherlands
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
in-vitro diagnostics, hematology analyzers, clinical flow cytometry, molecular diagnostics, urinalysis systems
Industry3 codes
PRIMARYHLAHAAAB
Hematology & Coagulation Diagnostics
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAHACAL
Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLAMADAA
Reference Laboratory Testing (Clinical Pathology & Chemistry)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Diagnostics (Labs & Imaging)
NAICS code3 codes
  • Medical Laboratories621511
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Analytical Laboratory Instrument Manufacturing334516
SIC code3 codes
  • Services-Medical Laboratories8071
  • In Vitro & In Vivo Diagnostic Substances2835
  • Laboratory Analytical Instruments3826
Product category
In-Vitro Diagnostics
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Diagnostic Equipment Sales
TypeHardware Sales
Description

Sale of hematology analyzers, flow cytometers, urinalysis systems, and related diagnostic instrumentation to clinical laboratories and healthcare facilities.

sysmex.nl
2Reagents and Consumables
TypeSubscription Recurring
Description

Recurring revenue from specialized reagents, calibration solutions, and consumables required for Sysmex diagnostic analyzers operation.

sysmex.nl
3Service and Maintenance Contracts
TypeSubscription Recurring
Description

Technical support, preventive maintenance, breakdown service, and service contracts for diagnostic equipment installed at customer sites.

sysmex.nl
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
1Enterprise laboratory diagnostic solutions
ModelOtherBilling cadenceMulti-year contract
Notes

Custom quotation-based pricing for hematology analyzers, flow cytometers, urinalysis systems, and related equipment. Reagent and consumable pricing determined through direct sales engagement.

sysmex.nl
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Sysmex Netherlands & Belgium sells and services automated in-vitro diagnostic analyzers (hematology, urinalysis, flow cytometry, hemostasis, fecal immunochemical testing), proprietary reagents and consumables, molecular diagnostic assays (OSNA, OncoBEAM, SafeSEQ), and related laboratory instrumentation to clinical laboratories, hospitals, blood banks, and public health screening programs across the Netherlands and Belgium. The company also provides technical support, preventive maintenance, breakdown service, and customer training through its Caresphere Academy platform.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Dutch CRC screening program achieved 71.5% participation rate with over 1.5 million participants and 4.3% unfavorable FIT result rate
+4 more records
Product overview1 text field

Sysmex Netherlands & Belgium offers a comprehensive portfolio of medical diagnostic solutions spanning In-Vitro Diagnostics (hematology, hemostasis, urinalysis, clinical chemistry, flow cytometry, point-of-care, veterinary diagnostics), Life Science products (OSNA molecular diagnostics for sentinel lymph node analysis, liquid biopsy solutions using BEAMing and SafeSEQ NGS technologies, digital pathology), and Industry & Research instruments (NIR spectrometers, particle analyzers, SEM). The product ecosystem centers on the XN-Series automated hematology analyzers with specialized software modules including Blood Bank Mode, Body Fluid Mode, and PLT-F fluorescence platelet counting. Key platforms include the XF-1600 flow cytometer, OSNA molecular diagnostic system, Sentimag magnetic localization system, and SENTiFIT 270 fecal immunochemical test analyzer. The company also provides laboratory equipment for environmental safety and extensive educational support through Caresphere Academy.

Product and service20 records
1XN-Series Hematology Analyzers
CategoryHematology Analyzers
Description

Automated hematology analyzers (XN-1000, XN-2000, XN-550, XN-9000) providing complete blood counts, white blood cell differentials, and advanced diagnostic parameters for clinical laboratories.

2XE-5000 Hematology Analyzer
CategoryHematology Analyzers
Description

Previous-generation automated hematology analyzer with body fluid mode for cerebrospinal fluid, pleural, peritoneal, and synovial fluid analysis.

3UF-5000 Urinalysis Analyzer
CategoryUrinalysis Analyzers
Description

Automated urine analyzer with body fluid mode capability for clinical urine and body fluid diagnostics.

4UN-Series Urinalysis
CategoryUrinalysis Analyzers
Description

Automated urinalysis system providing comprehensive urine testing with technology that reveals additional diagnostic information.

5XF-1600 Flow Cytometer
CategoryFlow Cytometry Analyzers
Description

10-color flow cytometry platform with automation capabilities for clinical flow cytometry applications including lymphoproliferative syndrome diagnosis and B-CLL assessment.

6PS-10 Sample Preparation System
CategoryFlow Cytometry Accessories
Description

Automated sample preparation system for flow cytometry providing standardized and reproducible sample processing.

7OSNA (One-Step Nucleic Acid Amplification)
CategoryMolecular Diagnostics
Description

Molecular diagnostic assay for intraoperative sentinel lymph node analysis in breast, colorectal, gastric, gynecological, lung, and prostate cancers using CK19 mRNA detection.

8OncoBEAM RAS CRC Assay
CategoryMolecular Diagnostics
Description

BEAMing-based liquid biopsy test for RAS mutation detection in circulating tumor DNA for metastatic colorectal cancer patients to guide anti-EGFR therapy decisions.

9SafeSEQ NGS Technology
CategoryMolecular Diagnostics
Description

Next-generation sequencing technology for ultrasensitive circulating tumor DNA detection, minimal residual disease monitoring, and multi-analyte liquid biopsy applications across various cancers.

10Sentimag/Sienna+ System
CategorySurgical Localization Systems
Description

Magnetic sentinel lymph node localization system using superparamagnetic iron oxide nanoparticles as an alternative to radiotracer for breast and prostate cancer surgery.

11DI-60 Digital Imaging System
CategoryDigital Pathology
Description

Automated digital microscopy system for body fluid cell analysis and tumor cell detection, providing faster screening with accuracy comparable to manual microscopy.

12SENTiFIT 270 Analyzer
CategoryFecal Analysis
Description

Automated fecal immunochemical test (FIT) analyzer for quantitative determination of fecal hemoglobin in colorectal cancer screening programs.

13FOB Gold FIT
CategoryFecal Analysis Reagents
Description

Latex fecal immunochemical test for quantitative detection of fecal hemoglobin, used in population-based colorectal cancer screening programs.

14CALiaGold Calprotectin Assay
CategoryFecal Analysis Reagents
Description

Quantitative latex immunoassay for fecal calprotectin measurement on SENTiFIT 270 analyzer for IBD diagnosis and monitoring.

15NIR Spectrometers (Industry & Research)
CategoryIndustry & Research Instruments
Description

Near-infrared spectrometers for industrial and research applications including material analysis.

16Particle Size and Shape Analyzers
CategoryIndustry & Research Instruments
Description

Instruments from Malvern Panalytical for analyzing particle size distribution and particle shape characteristics in laboratory settings.

17SEM (Scanning Electron Microscopy)
CategoryIndustry & Research Instruments
Description

Scanning electron microscopy solutions for Industry & Research applications.

18Environmental & Safety Products
CategoryEnvironmental Safety Equipment
Description

Solutions including gas detection systems, acoustic cameras, air sampling equipment, fit testing, formaldehyde detection, and noise measurement for environmental monitoring and workplace safety.

19Veterinary Solutions
CategoryVeterinary Diagnostics
Description

In-vitro diagnostics solutions tailored for veterinary applications.

20Point-of-Care Testing
CategoryPoint-of-Care Diagnostics
Description

Rapid diagnostic testing solutions for point-of-care settings.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Leading molecular diagnostics and sample-preparation vendor with QIAstat-Dx, digene HPV, and circulating tumor DNA assays. Competitor in liquid biopsy and companion diagnostics segments where Sysmex SafeSEQ and OncoBEAM operate.

TypeEmerging player
Description

Chinese IVD manufacturer rapidly expanding in Europe with BC-7500/BC-7600 hematology and chemiluminescence analyzers. Targets mid-tier and high-volume labs with lower-priced alternatives to Sysmex and Beckman Coulter.

TypeDirect peer
Description

Japanese parent company that designs and manufactures the XN-series hematology, flow cytometry, urinalysis and molecular diagnostic platforms that Sysmex NL/BE sells. Direct strategic parent and obvious functional peer.

TypeBroad incumbent
Description

Global IVD leader with cobas hematology, clinical chemistry, immunoassay and molecular diagnostics suites. Serves the same NL/BE hospital and reference lab customers with a broader portfolio.

5Beckman Coulter (Danaher)
TypeDirect peer
Description

Direct competitor in hematology and clinical chemistry IVD analyzers with deep installed base in European hospital labs. Comparable product menu (DxH series) and recurring reagent model.

TypeRegional player
Description

Strong in women's health, oncology, and molecular diagnostics (e.g., Panther system). Overlaps with Sysmex's OSNA and liquid biopsy franchise in hospital oncology workflows.

TypeBroad incumbent
Description

Specializes in microbiology and infectious disease diagnostics, with growing immunoassay and clinical flow cytometry presence. Overlaps with Sysmex in clinical lab diagnostics and to some extent in flow cytometry.

TypeBroad incumbent
Description

Operates the Atellica and ADVIA Centaur hematology/chemistry/immunoassay lines plus extensive lab automation. Comparable enterprise sales motion to hospitals and reference labs in NL/BE.

TypeRegional player
Description

Specializes in immunoassay and clinical chemistry (Vitros systems) with strong blood-bank screening presence. Overlaps with Sysmex in blood-bank QC and clinical chemistry adjacencies.

10Abbott Diagnostics
TypeBroad incumbent
Description

Major IVD incumbent with CELL-DYN hematology, Alinity ci clinical chemistry/immunoassay, and molecular diagnostics. Competes head-to-head for hospital lab contracts across Benelux.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature11 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Sysmex Netherlands & Belgium

In-Vitro Diagnosticssysmex.nl

Sysmex Netherlands & Belgium is the Benelux sales and service arm of Sysmex Corporation, distributing automated hematology analyzers, flow cytometry, urinalysis, molecular diagnostics, and life science platforms to clinical laboratories, hospitals, blood banks, and government screening programs in the Netherlands and Belgium.

What Sysmex Netherlands & Belgium does

Sysmex Netherlands & Belgium is the Benelux operating arm of Sysmex Corporation, structured as two regional subsidiaries (Sysmex Nederland B.V., headquartered in Etten-Leur, and Sysmex Belgium N.V., in La Hulpe) under Sysmex Europe SE. The business distributes and services a comprehensive in-vitro diagnostics portfolio to clinical laboratories, hospitals, blood banks, oncology centers, and government screening programs in the Netherlands and Belgium, employing approximately 180 staff.

The product platform is anchored by the XN-Series automated hematology analyzers, with proprietary software modules (Blood Bank Mode, Body Fluid Mode, PLT-F fluorescence platelet counting) and an Extended IPU enabling advanced parameters such as ICIS for sepsis screening and MDS-CBC for myelodysplastic syndrome detection. The Life Science portfolio includes the OSNA molecular diagnostic platform for intraoperative sentinel lymph node analysis, OncoBEAM RAS CRC liquid biopsy, SafeSEQ NGS-based ctDNA detection, the XF-1600 10-color flow cytometer, the DI-60 digital imaging system, and the Sentimag magnetic localization system. Adjacent offerings span hemostasis, urinalysis, clinical chemistry, point-of-care testing, veterinary diagnostics, and Industry & Research instrumentation distributed via a partnership with Malvern Panalytical.

Revenue is generated through three streams: capital equipment sales (hematology, flow cytometry, urinalysis analyzers), recurring reagents and consumables tied to the installed base, and multi-year service and maintenance contracts. The go-to-market is direct enterprise field sales combined with in-house technical support, preventive maintenance, and customer training delivered through Caresphere Academy. Customer engagement includes the Dutch National Colorectal Cancer Screening Programme using the SENTiFIT 270 analyzer and FOB Gold reagents, which has scaled to over 1.5 million participants.

Sysmex Netherlands & Belgium firmographics

Firmographics
Name
Sysmex Netherlands & Belgium
Legal name
Sysmex Nederland B.V.
Website
https://sysmex.nl
Company type
Private
Operating status
Operating
Headcount range
101–250 employees
Short description
Sysmex Netherlands & Belgium is the Benelux sales and service arm of Sysmex Corporation, distributing automated hematology analyzers, flow cytometry, urinalysis, molecular diagnostics, and life science platforms to clinical laboratories, hospitals, blood banks, and government screening programs in the Netherlands and Belgium.
Ownership category
akta.pro rank

Sysmex Netherlands & Belgium industry classification

Industry
Product category
In-Vitro Diagnostics
NAICS
Medical Laboratories (621511), In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)
SIC
Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLAHAAAB
Hematology & Coagulation Diagnostics
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAHACAL
Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLAMADAA
Reference Laboratory Testing (Clinical Pathology & Chemistry)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Diagnostics (Labs & Imaging)

Keywords

  • In-vitro diagnostics
  • Hematology analyzers
  • Clinical flow cytometry
  • Molecular diagnostics
  • Urinalysis systems

Where Sysmex Netherlands & Belgium is headquartered

Location

Headquarters

HQ city
Etten-Leur
HQ country
Netherlands
HQ region
Europe

Offices2 records

Markets served

Sysmex Netherlands & Belgium business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Diagnostic Equipment Sales: Sale of hematology analyzers, flow cytometers, urinalysis systems, and related diagnostic instrumentation to clinical laboratories and healthcare facilities.
  2. Reagents and Consumables: Recurring revenue from specialized reagents, calibration solutions, and consumables required for Sysmex diagnostic analyzers operation.
  3. Service and Maintenance Contracts: Technical support, preventive maintenance, breakdown service, and service contracts for diagnostic equipment installed at customer sites.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractEnterprise laboratory diagnostic solutions

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Sysmex Netherlands & Belgium product offering

Product offering

Core offering

Sysmex Netherlands & Belgium sells and services automated in-vitro diagnostic analyzers (hematology, urinalysis, flow cytometry, hemostasis, fecal immunochemical testing), proprietary reagents and consumables, molecular diagnostic assays (OSNA, OncoBEAM, SafeSEQ), and related laboratory instrumentation to clinical laboratories, hospitals, blood banks, and public health screening programs across the Netherlands and Belgium. The company also provides technical support, preventive maintenance, breakdown service, and customer training through its Caresphere Academy platform.

Product overview

Sysmex Netherlands & Belgium offers a comprehensive portfolio of medical diagnostic solutions spanning In-Vitro Diagnostics (hematology, hemostasis, urinalysis, clinical chemistry, flow cytometry, point-of-care, veterinary diagnostics), Life Science products (OSNA molecular diagnostics for sentinel lymph node analysis, liquid biopsy solutions using BEAMing and SafeSEQ NGS technologies, digital pathology), and Industry & Research instruments (NIR spectrometers, particle analyzers, SEM). The product ecosystem centers on the XN-Series automated hematology analyzers with specialized software modules including Blood Bank Mode, Body Fluid Mode, and PLT-F fluorescence platelet counting. Key platforms include the XF-1600 flow cytometer, OSNA molecular diagnostic system, Sentimag magnetic localization system, and SENTiFIT 270 fecal immunochemical test analyzer. The company also provides laboratory equipment for environmental safety and extensive educational support through Caresphere Academy.

Differentiator

Problem solved

Functional benefit

Products and services

  • XN-Series Hematology Analyzers Automated hematology analyzers (XN-1000, XN-2000, XN-550, XN-9000) providing complete blood counts, white blood cell differentials, and advanced diagnostic parameters for clinical laboratories.
  • XE-5000 Hematology Analyzer Previous-generation automated hematology analyzer with body fluid mode for cerebrospinal fluid, pleural, peritoneal, and synovial fluid analysis.
  • UF-5000 Urinalysis Analyzer Automated urine analyzer with body fluid mode capability for clinical urine and body fluid diagnostics.
  • UN-Series Urinalysis Automated urinalysis system providing comprehensive urine testing with technology that reveals additional diagnostic information.
  • XF-1600 Flow Cytometer 10-color flow cytometry platform with automation capabilities for clinical flow cytometry applications including lymphoproliferative syndrome diagnosis and B-CLL assessment.
  • PS-10 Sample Preparation System Automated sample preparation system for flow cytometry providing standardized and reproducible sample processing.
  • OSNA (One-Step Nucleic Acid Amplification) Molecular diagnostic assay for intraoperative sentinel lymph node analysis in breast, colorectal, gastric, gynecological, lung, and prostate cancers using CK19 mRNA detection.
  • OncoBEAM RAS CRC Assay BEAMing-based liquid biopsy test for RAS mutation detection in circulating tumor DNA for metastatic colorectal cancer patients to guide anti-EGFR therapy decisions.
  • SafeSEQ NGS Technology Next-generation sequencing technology for ultrasensitive circulating tumor DNA detection, minimal residual disease monitoring, and multi-analyte liquid biopsy applications across various cancers.
  • Sentimag/Sienna+ System Magnetic sentinel lymph node localization system using superparamagnetic iron oxide nanoparticles as an alternative to radiotracer for breast and prostate cancer surgery.
  • DI-60 Digital Imaging System Automated digital microscopy system for body fluid cell analysis and tumor cell detection, providing faster screening with accuracy comparable to manual microscopy.
  • SENTiFIT 270 Analyzer Automated fecal immunochemical test (FIT) analyzer for quantitative determination of fecal hemoglobin in colorectal cancer screening programs.
  • FOB Gold FIT Latex fecal immunochemical test for quantitative detection of fecal hemoglobin, used in population-based colorectal cancer screening programs.
  • CALiaGold Calprotectin Assay Quantitative latex immunoassay for fecal calprotectin measurement on SENTiFIT 270 analyzer for IBD diagnosis and monitoring.
  • NIR Spectrometers (Industry & Research) Near-infrared spectrometers for industrial and research applications including material analysis.
  • Particle Size and Shape Analyzers Instruments from Malvern Panalytical for analyzing particle size distribution and particle shape characteristics in laboratory settings.
  • SEM (Scanning Electron Microscopy) Scanning electron microscopy solutions for Industry & Research applications.
  • Environmental & Safety Products Solutions including gas detection systems, acoustic cameras, air sampling equipment, fit testing, formaldehyde detection, and noise measurement for environmental monitoring and workplace safety.
  • Veterinary Solutions In-vitro diagnostics solutions tailored for veterinary applications.
  • Point-of-Care Testing Rapid diagnostic testing solutions for point-of-care settings.

Quantifiable outcome

  • Dutch CRC screening program achieved 71.5% participation rate with over 1.5 million participants and 4.3% unfavorable FIT result rate
  • +4 more outcomes

Companies that use Sysmex Netherlands & Belgium

Customer profile

Named customers4 records

Segments5 records

Ideal customer profiles4 records

Sysmex Netherlands & Belgium technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature11 records

Sysmex Netherlands & Belgium partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Sysmex Netherlands & Belgium competitors and assessment

Company assessment

Emerging players

  • QIAGEN: Leading molecular diagnostics and sample-preparation vendor with QIAstat-Dx, digene HPV, and circulating tumor DNA assays. Competitor in liquid biopsy and companion diagnostics segments where Sysmex SafeSEQ and OncoBEAM operate.
  • Mindray: Chinese IVD manufacturer rapidly expanding in Europe with BC-7500/BC-7600 hematology and chemiluminescence analyzers. Targets mid-tier and high-volume labs with lower-priced alternatives to Sysmex and Beckman Coulter.

Direct peers

  • Sysmex Corporation: Japanese parent company that designs and manufactures the XN-series hematology, flow cytometry, urinalysis and molecular diagnostic platforms that Sysmex NL/BE sells. Direct strategic parent and obvious functional peer.
  • Beckman Coulter (Danaher): Direct competitor in hematology and clinical chemistry IVD analyzers with deep installed base in European hospital labs. Comparable product menu (DxH series) and recurring reagent model.

Broad incumbents

  • Roche Diagnostics: Global IVD leader with cobas hematology, clinical chemistry, immunoassay and molecular diagnostics suites. Serves the same NL/BE hospital and reference lab customers with a broader portfolio.
  • bioMérieux: Specializes in microbiology and infectious disease diagnostics, with growing immunoassay and clinical flow cytometry presence. Overlaps with Sysmex in clinical lab diagnostics and to some extent in flow cytometry.
  • Siemens Healthineers: Operates the Atellica and ADVIA Centaur hematology/chemistry/immunoassay lines plus extensive lab automation. Comparable enterprise sales motion to hospitals and reference labs in NL/BE.
  • Abbott Diagnostics: Major IVD incumbent with CELL-DYN hematology, Alinity ci clinical chemistry/immunoassay, and molecular diagnostics. Competes head-to-head for hospital lab contracts across Benelux.

Regional players

  • Hologic: Strong in women's health, oncology, and molecular diagnostics (e.g., Panther system). Overlaps with Sysmex's OSNA and liquid biopsy franchise in hospital oncology workflows.
  • Ortho Clinical Diagnostics: Specializes in immunoassay and clinical chemistry (Vitros systems) with strong blood-bank screening presence. Overlaps with Sysmex in blood-bank QC and clinical chemistry adjacencies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Sysmex Netherlands & Belgium social profiles

Digital presence

Sysmex Netherlands & Belgium financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Sysmex Netherlands & Belgium leadership team

Management profile

Number of profiles

Profiles1 record

Sysmex Netherlands & Belgium funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Sysmex Netherlands & Belgium M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sysmex Netherlands & Belgium

What does Sysmex Netherlands & Belgium do?

Sysmex Netherlands & Belgium sells and services automated in-vitro diagnostic analyzers (hematology, urinalysis, flow cytometry, hemostasis, fecal immunochemical testing), proprietary reagents and consumables, molecular diagnostic assays (OSNA, OncoBEAM, SafeSEQ), and related laboratory instrumentation to clinical laboratories, hospitals, blood banks, and public health screening programs across the Netherlands and Belgium. The company also provides technical support, preventive maintenance, breakdown service, and customer training through its Caresphere Academy platform.

Is Sysmex Netherlands & Belgium a public or private company?

Sysmex Netherlands & Belgium is a private company. It is classified as corporate owned and is currently operating.

When was Sysmex Netherlands & Belgium founded?

Sysmex Netherlands & Belgium was founded in -1. It employs 101 to 250 people.

Where is Sysmex Netherlands & Belgium based?

Sysmex Netherlands & Belgium is headquartered in Etten-Leur, Netherlands, in the Europe region.

How does Sysmex Netherlands & Belgium make money?

Three revenue lines are on record. Diagnostic Equipment Sales are the primary driver. The others are reagents and Consumables and service and Maintenance Contracts.

Who are Sysmex Netherlands & Belgium's main competitors?

Emerging players on record are QIAGEN and Mindray. Direct peers are Sysmex Corporation and Beckman Coulter (Danaher). Broad incumbents are Roche Diagnostics, bioMérieux, Siemens Healthineers and Abbott Diagnostics. Regional players are Hologic and Ortho Clinical Diagnostics.

Does Sysmex Netherlands & Belgium have an API?

No public API is recorded for Sysmex Netherlands & Belgium.

What industry is Sysmex Netherlands & Belgium in?

Sysmex Netherlands & Belgium's product category is In-Vitro Diagnostics. Its primary akta.pro industry code is HLAHAAAB, Hematology & Coagulation Diagnostics, with a secondary code of HLAHACAL, Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers). Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales